Figure 1From: Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM Decreased miR-106a confers a poor prognosis in GBMs. (A) Real time PCR was employed to measure the expression of miR-106a in glioma specimens and normal tissues. (B) Kaplan-Meier survival curves for miR-106a expression in GBM of TCGA data.Back to article page